Bottom line
How much do VGHCX and IDNA overlap?
17% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 14.1% of VGHCX's assets and 19.6% of IDNA's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings VGHCX and IDNA have in common
| Holding | % of VGHCX | % of IDNA | Overlap |
|---|---|---|---|
| Merck & Co Inc | 5.44% | 3.91% | 3.91% |
| Gsk Plc | 3.00% | 3.63% | 3.00% |
| Vertex Pharmaceuticals Inc | 2.36% | 3.87% | 2.36% |
| Regeneron Pharmaceuticals Inc | 2.14% | 4.35% | 2.14% |
| Roche Holding AG | 1.18% | 3.85% | 1.18% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in VGHCX
- Eli Lilly & Co — 8.61%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
- AbbVie Inc — 2.30%
- Danaher Corp — 2.18%
- Novartis AG — 1.91%
- Elevance Health Inc — 1.83%
- Argenx SE — 1.68%
- HCA Healthcare Inc — 1.68%
- Ucb Sa — 1.67%
Only in IDNA
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
- Bayer Aktiengesellschaft — 4.81%
- Twist Bioscience Corp — 4.79%
- Revolution Medicines, Inc. — 4.55%
- Genmab A/s — 4.23%
- Incyte Corporation — 4.23%
- Moderna, Inc. — 4.19%
- Takeda Pharmaceutical Company Limited — 4.05%
- Ipsen Sa — 3.84%
- BioNTech SE — 3.73%
- Exelixis, Inc. — 3.65%
- Sanofi Sa — 3.46%
- IDEAYA Biosciences Inc — 3.36%
- Immunitybio Inc — 3.07%
- Arcus Biosciences, Inc. — 2.68%
Asset mix
| Asset type | VGHCX | IDNA |
|---|---|---|
| Stocks | 97.6% | 96.0% |
| Cash & short-term funds | 0.1% | 10.5% |
| Other | — | 3.8% |
| Repurchase agreements | 2.2% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | VGHCX | IDNA |
|---|---|---|
| US | 77.6% | 70.2% |
| DE | — | 8.5% |
| FR | — | 7.8% |
| GB | 7.6% | 3.7% |
| JP | 4.8% | 6.0% |
| CH | 4.5% | 5.4% |
| DK | 1.4% | 4.2% |
| BE | 3.4% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do VGHCX and IDNA overlap?
What stocks do VGHCX and IDNA have in common?
Should I own both VGHCX and IDNA?
Which holds more stocks, VGHCX or IDNA?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.